Final Analysis of a Phase II Study: Anlotinib Plus Docetaxel in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer

被引：0

作者：

Shen, J. ^{[1
]}

Huang, J. ^{[2
]}

Li, X. ^{[1
]}

Xia, B. ^{[2
]}

Wang, B. ^{[2
]}

Yang, S. ^{[1
]}

Wu, K. ^{[2
]}

Zhang, M. ^{[2
]}

Wang, J. ^{[1
]}

Zhao, P. ^{[2
]}

Chen, X. ^{[1
]}

Ma, S. ^{[2
]}

机构：

[1] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China

[2] Zhejiang Univ, Affiliated Hangzhou Canc Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China

来源：

关键词：

Non-small cell lung cancer; Anlotinib; docetaxel;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP08.02-13

引用

页码：S467 / S468

页数：2